miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer.
• Dysregulation of specific miRNAs contributes to carcinogenesis and tumor progression.
• The role of miR-133a in colorectal cancer (CRC) pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the function and molecular mechanisms of miR-133a in colorectal cancer.
• To identify direct target genes of miR-133a relevant to CRC.
• To assess the therapeutic potential of miR-133a in colorectal cancer models.

Main Methods:

• Quantitative analysis of miR-133a expression in tumor tissues and cell lines.
• In vitro assays (cell viability, colony formation, migration, invasion) to assess miR-133a function.
• In vivo xenograft tumor growth studies in nude mice.
• Luciferase reporter assays to validate direct target genes.

Main Results:

• miR-133a expression was significantly downregulated in colorectal tumor tissues and cell lines.
• Ectopic miR-133a expression inhibited cell proliferation, migration, and invasion in vitro.
• Overexpression of miR-133a reduced tumor growth in vivo.
• Eukaryotic translation initiation factor 4A1 (eIF4A1) was identified as a direct target of miR-133a.
• miR-133a's tumor-suppressive effects were dependent on targeting eIF4A1.

Conclusions:

• miR-133a functions as a tumor suppressor in colorectal cancer.
• miR-133a inhibits proliferation, migration, and invasion by targeting oncogenic eIF4A1.
• miR-133a represents a potential therapeutic target for colorectal cancer treatment.